Free RSV vaccines for pregnant women and newborn babies! Discover how this new program will reduce hospitalisations and keep our littlest Australians safe!
In a groundbreaking move, the Australian government is set to roll out free vaccinations for pregnant mothers and newborns against respiratory syncytial virus (RSV). This respiratory virus causes a staggering number of hospitalisations among infants, with around 12,000 babies admitted every winter. The national immunisation program aims to lower these concerning statistics, ensuring a healthier start for our future generation. Expecting mothers can now breathe a sigh of relief knowing they have access to this vital immunisation, helping protect both themselves and their little ones from the nasty effects of RSV.
The initiative comes at a critical time as RSV cases have spiked significantly—over 37,000 cases reported! With winter fast approaching, it's a timely solution for families across Australia. This new vaccine program is heralded as a significant step toward safeguarding our infants who are incredibly vulnerable during cold and flu season. Simply put, better protection for pregnant mums and newborns means fewer hospital stays and healthier babies! It's a win-win that has everyone cheering.
The Albanese government’s commitment to this immunisation program is more than just about numbers; it's a reflection of Australia's dedication to maternal and child health. By simply getting vaccinated, pregnant women can transfer antibodies to their babies, providing an extra layer of protection. These proactive measures aim to keep over 10,000 babies out of the hospital, which is truly remarkable in terms of public health initiatives.
It’s not just about vaccines, but about the community coming together to protect our littlest Australians. With this new approach, the focus is shifting to preventative care rather than reactive responses to illnesses. So, here’s to fewer baby hospital visits and more healthy giggles!
Did you know? RSV is the leading cause of severe respiratory illness in infants and young children, which makes this new program crucial. Also, the vaccine will not only benefit newborns but will also significantly reduce the stress on healthcare systems during peak RSV season! Talk about a double win for our health care heroes!
A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to lower childhood hospitalisations by ...
The federal government will place RSV vaccines on the national immunisation program, as 12000 babies are hospitalised with the virus each winter.
The federal government will provide free access to vaccines protecting expectant mums and babies from respiratory syncytial virus.
The respiratory virus is the leading cause of hospitalisation for infants, with 12000 babies admitted each year. Before next winter, protection for mums and ...
Pregnant mums and newborns will receive free vaccinations against respiratory syncytial virus (RSV) under t...
Immunisation advocates are heralding the Albanese Government's commitment to the first all-infant RSV (respiratory syncytial virus) immunisation program as a ...
CANBERRA, Nov. 10 (Xinhua) -- The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and ...
The move will give free access to Abrysvo, a maternal RSV vaccine, under the National Immunisation Program (NIP), in line with a Pharmaceutical Benefits ...
The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...
In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation Program ...
In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation Program ...
A NATIONWIDE immunisation program has been launched to shield infants from severe respiratory syncytial virus (RSV), which includes Sanofi's Beyfortus ...